Skip to main content
Erschienen in: Herz 4/2017

12.05.2017 | Elektrische und interventionelle Therapie des Vorhofflimmerns | Schwerpunkt

Katheterablation von persistierendem Vorhofflimmern

„Where do we go?“

verfasst von: Dr. med. C. Lemeš, K.-H. Kuck, S. Mathew

Erschienen in: Herz | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Katheterablation von persistierendem Vorhofflimmern (VHF) bleibt trotz initial vielversprechender erster klinischer Studienergebnisse eine Herausforderung in der Elektrophysiologie. Auf Basis der angenommenen pathophysiologischen Mechanismen haben sich im Laufe der Zeit verschiedene Ablationsstrategien entwickelt. So reichen die aktuellen Ablationsstrategien von der alleinigen Pulmonalvenenisolation (PVI) als Erstlinientherapie über die Anlage von multiplen Ablationslinien, Ablation von komplex fraktionierten atrialen Elektrogrammen (CFAE), Rotorablationen, Isolation von Fibrose- bzw. Narbenarealen bis zur LAA („left atrial appendage“)-Isolation. Unklar ist jedoch bis zum heutigen Tag, ob diese komplexeren und zeitaufwändigeren Strategien tatsächlich die Erfolgsraten der Ablationstherapie verbessern. In den letzten Jahren zeigte sich reproduzierbar, dass mit den oben geschilderten Ablationstechniken häufig mehr als eine Prozedur nötig ist, um einen stabilen Sinusrhythmus zu erreichen, und trotzdem nur von bedingt zufriedenstellenden Erfolgsraten auszugehen ist. Als einziger derzeit etablierter Ablationsendpunkt gilt die PVI. Als additives Konzept zur Ablation rückt die stringente Behandlung von Risikofaktoren wie arterieller Hypertonus oder Adipositas zunehmend in den Therapiefokus.
Literatur
1.
Zurück zum Zitat Kerr CR, Humphries KH, Talajic M et al (2005) Progression to chronic atrial fibrillation after initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J 149:489–496CrossRefPubMed Kerr CR, Humphries KH, Talajic M et al (2005) Progression to chronic atrial fibrillation after initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J 149:489–496CrossRefPubMed
2.
Zurück zum Zitat De Vos CB, Pisters R, Nieuwlaat R et al (2010) Progression from paroxysmal to persistent atrial fibrillation: clinical correlates and prognosis. J Am Coll Cardiol 55:725–731CrossRefPubMed De Vos CB, Pisters R, Nieuwlaat R et al (2010) Progression from paroxysmal to persistent atrial fibrillation: clinical correlates and prognosis. J Am Coll Cardiol 55:725–731CrossRefPubMed
3.
Zurück zum Zitat Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893–2962CrossRefPubMed Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893–2962CrossRefPubMed
4.
Zurück zum Zitat Pathak RK, Elliott A, Middeldorp ME et al (2015) Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am Coll Cardiol 66:985–996CrossRefPubMed Pathak RK, Elliott A, Middeldorp ME et al (2015) Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am Coll Cardiol 66:985–996CrossRefPubMed
5.
Zurück zum Zitat Abed HS, Wittert GA, Leong DP et al (2013) Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. J Am Med Assoc 310:2050–2060CrossRef Abed HS, Wittert GA, Leong DP et al (2013) Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. J Am Med Assoc 310:2050–2060CrossRef
6.
Zurück zum Zitat Pathak RK, Middeldorp ME, Meredith M et al (2015) Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol 65:2159–2169CrossRefPubMed Pathak RK, Middeldorp ME, Meredith M et al (2015) Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol 65:2159–2169CrossRefPubMed
7.
Zurück zum Zitat Haissaguerre M, Jais P, Shah DC et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666CrossRefPubMed Haissaguerre M, Jais P, Shah DC et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666CrossRefPubMed
8.
Zurück zum Zitat Moe GK et al (1962) On the multiple wavelet hypothesus of AF. Arch Int Pharmacondyn Ther 140:183–188 Moe GK et al (1962) On the multiple wavelet hypothesus of AF. Arch Int Pharmacondyn Ther 140:183–188
9.
Zurück zum Zitat Allessie MA, Bonke FI, Schopman FJ et al (1973) Circus movement in rabbit atrial muscle as a mechanism of tachycardia. Circ Res 33:54–62CrossRefPubMed Allessie MA, Bonke FI, Schopman FJ et al (1973) Circus movement in rabbit atrial muscle as a mechanism of tachycardia. Circ Res 33:54–62CrossRefPubMed
10.
Zurück zum Zitat Dagres N, Bongiorni MG, Larsen TB et al (2015) Scientific Initiatives Committee, European Heart Rhythm Association. Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey. Europace 17:1596–1600CrossRefPubMed Dagres N, Bongiorni MG, Larsen TB et al (2015) Scientific Initiatives Committee, European Heart Rhythm Association. Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey. Europace 17:1596–1600CrossRefPubMed
11.
Zurück zum Zitat Kuck KH, Hoffmann BA, Ernst S et al (2016) Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 Trial. Circ Arrhythm Electrophysiol 9(1):e003337. doi:10.1161/CIRCEP.115.003337 CrossRefPubMed Kuck KH, Hoffmann BA, Ernst S et al (2016) Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 Trial. Circ Arrhythm Electrophysiol 9(1):e003337. doi:10.​1161/​CIRCEP.​115.​003337 CrossRefPubMed
12.
Zurück zum Zitat Straube F, Dorwarth U, Ammar-Busch S et al (2016) First-line catheter ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation. Europace 18:368–375CrossRefPubMed Straube F, Dorwarth U, Ammar-Busch S et al (2016) First-line catheter ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation. Europace 18:368–375CrossRefPubMed
13.
Zurück zum Zitat Luik A, Radzewitz A, Kieser M et al (2015) Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective, randomized, con- trolled, noninferiority FreezeAF study. Circulation 132:1311–1319CrossRefPubMedPubMedCentral Luik A, Radzewitz A, Kieser M et al (2015) Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective, randomized, con- trolled, noninferiority FreezeAF study. Circulation 132:1311–1319CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Tilz RR, Rillig A, Thum AM et al (2012) Catheter ablation of long-standing persistent atrial fibrillation: 5‑year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol 60(19):1921–1929CrossRefPubMed Tilz RR, Rillig A, Thum AM et al (2012) Catheter ablation of long-standing persistent atrial fibrillation: 5‑year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol 60(19):1921–1929CrossRefPubMed
15.
Zurück zum Zitat Lemes C, Wissner E, Lin T et al (2016) One-year clinical outcome after pulmonary vein isolation in persistent atrial fibrillation using the second-generation 28 mm cryoballoon: a retrospective analysis. Europace 18(2):201–205CrossRefPubMed Lemes C, Wissner E, Lin T et al (2016) One-year clinical outcome after pulmonary vein isolation in persistent atrial fibrillation using the second-generation 28 mm cryoballoon: a retrospective analysis. Europace 18(2):201–205CrossRefPubMed
16.
Zurück zum Zitat Brooks AG, Stiles MK, Laborderie J et al (2010) Outcomes of long-standing persistent atrial fibrillation ablation: A systematic review. Heart Rhythm 7(6):835–846CrossRefPubMed Brooks AG, Stiles MK, Laborderie J et al (2010) Outcomes of long-standing persistent atrial fibrillation ablation: A systematic review. Heart Rhythm 7(6):835–846CrossRefPubMed
17.
Zurück zum Zitat Arbelo E, Brugada J, Hindricks G et al (2014) The atrial fibrillation ablation pilot study: a European survey on methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. Eur Heart J 35:1466–1478CrossRefPubMed Arbelo E, Brugada J, Hindricks G et al (2014) The atrial fibrillation ablation pilot study: a European survey on methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. Eur Heart J 35:1466–1478CrossRefPubMed
18.
Zurück zum Zitat Cox JL, Boineau JP, Schuessler RB et al (1993) Five-year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg 56:814–824CrossRefPubMed Cox JL, Boineau JP, Schuessler RB et al (1993) Five-year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg 56:814–824CrossRefPubMed
19.
Zurück zum Zitat Nademanee K, McKenzie J, Kosar E et al (2004) A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 43:2044–2053CrossRefPubMed Nademanee K, McKenzie J, Kosar E et al (2004) A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 43:2044–2053CrossRefPubMed
20.
Zurück zum Zitat Verma A, Sanders P, Macle L et al (2012) Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): design and rationale. Am Heart J 164(1):1–6CrossRefPubMed Verma A, Sanders P, Macle L et al (2012) Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): design and rationale. Am Heart J 164(1):1–6CrossRefPubMed
21.
Zurück zum Zitat Vogler J, Willems S, Sultan A et al (2015) Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial. J Am Coll Cardiol 66(24):2743–2752CrossRefPubMed Vogler J, Willems S, Sultan A et al (2015) Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial. J Am Coll Cardiol 66(24):2743–2752CrossRefPubMed
22.
Zurück zum Zitat Peters DC, Wylie JV, Hauser TH et al (2007) Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology 243(3):690–695CrossRefPubMed Peters DC, Wylie JV, Hauser TH et al (2007) Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology 243(3):690–695CrossRefPubMed
23.
Zurück zum Zitat McGann CJ, Kholmovski EG, Oakes RS et al (2008) New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol 52(15):1263–1271CrossRefPubMed McGann CJ, Kholmovski EG, Oakes RS et al (2008) New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol 52(15):1263–1271CrossRefPubMed
24.
Zurück zum Zitat Oakes RS, Badger TJ, Kholmovski EG et al (2009) Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119(13):1758–1767CrossRefPubMedPubMedCentral Oakes RS, Badger TJ, Kholmovski EG et al (2009) Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119(13):1758–1767CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Marrouche NF, Wilber D, Hindricks G et al (2014) Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation. JAMA 311(5):498–499CrossRefPubMed Marrouche NF, Wilber D, Hindricks G et al (2014) Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation. JAMA 311(5):498–499CrossRefPubMed
26.
Zurück zum Zitat Kottkamp H, Berg J, Bender R et al (2016) Box Isolation of Fibrotic Areas (BIFA): a patient-tailored substrate modification approach for ablation of atrial fibrillation. J Cardiovasc Electrophysiol 27(1):22–30CrossRefPubMed Kottkamp H, Berg J, Bender R et al (2016) Box Isolation of Fibrotic Areas (BIFA): a patient-tailored substrate modification approach for ablation of atrial fibrillation. J Cardiovasc Electrophysiol 27(1):22–30CrossRefPubMed
27.
Zurück zum Zitat Di Biase L, Burkhardt JD, Mohanty P et al (2010) Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation 122(2):109–118CrossRefPubMed Di Biase L, Burkhardt JD, Mohanty P et al (2010) Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation 122(2):109–118CrossRefPubMed
28.
Zurück zum Zitat Di Biase L, Burkhardt JD, Mohanty P et al (2016) Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol 68(18):1929–1940CrossRefPubMed Di Biase L, Burkhardt JD, Mohanty P et al (2016) Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol 68(18):1929–1940CrossRefPubMed
29.
Zurück zum Zitat Rillig A, Tilz RR, Lin T et al (2016) Unexpectedly high incidence of stroke and left atrial appendage thrombus formation after electrical isolation of the left atrial appendage for the treatment of atrial tachyarrhythmias. Circ Arrhythm Electrophysiol 9(5):e003461. doi:10.1161/CIRCEP.115.003461 CrossRefPubMed Rillig A, Tilz RR, Lin T et al (2016) Unexpectedly high incidence of stroke and left atrial appendage thrombus formation after electrical isolation of the left atrial appendage for the treatment of atrial tachyarrhythmias. Circ Arrhythm Electrophysiol 9(5):e003461. doi:10.​1161/​CIRCEP.​115.​003461 CrossRefPubMed
30.
Zurück zum Zitat Santangeli P, Zado ES, Hutchinson MD et al (2016) Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation. Heart Rhythm 13(2):374–382CrossRefPubMed Santangeli P, Zado ES, Hutchinson MD et al (2016) Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation. Heart Rhythm 13(2):374–382CrossRefPubMed
31.
Zurück zum Zitat Narayan SM, Patel J, Mulpuru S et al (2012) Focal impulse and rotor modulation ablation of sustaining rotors abruptly terminates persistent atrial fibrillation to sinus rhythm with elimination on follow-up: a video case study. Heart Rhythm 9:1436–1439CrossRefPubMedPubMedCentral Narayan SM, Patel J, Mulpuru S et al (2012) Focal impulse and rotor modulation ablation of sustaining rotors abruptly terminates persistent atrial fibrillation to sinus rhythm with elimination on follow-up: a video case study. Heart Rhythm 9:1436–1439CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Tilz RR, Lin T, Rillig A et al (2016) Focal impulse and rotor modulation for the treatment of atrial fibrillation: locations and one year outcomes of human rotors identified using a 64-electrode basket catheter. J Cardiovasc Electrophysiol. doi:10.1111/jce.13157 Tilz RR, Lin T, Rillig A et al (2016) Focal impulse and rotor modulation for the treatment of atrial fibrillation: locations and one year outcomes of human rotors identified using a 64-electrode basket catheter. J Cardiovasc Electrophysiol. doi:10.​1111/​jce.​13157
33.
Zurück zum Zitat Narayan SM, Krummen DE, Shivkumar K et al (2012) Treatment of atrial fibrillation by the ablation of localized sources: the Con- ventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation (CONFIRM) trial. J Am Coll Cardiol 60:628–636CrossRefPubMedPubMedCentral Narayan SM, Krummen DE, Shivkumar K et al (2012) Treatment of atrial fibrillation by the ablation of localized sources: the Con- ventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation (CONFIRM) trial. J Am Coll Cardiol 60:628–636CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Narayan SM, Krummen DE, Shivkumar K et al (2012) Treatment of atrial fibrillation by the ablation of localized sources. J Am Coll Cardiol 60(7):628–636CrossRefPubMedPubMedCentral Narayan SM, Krummen DE, Shivkumar K et al (2012) Treatment of atrial fibrillation by the ablation of localized sources. J Am Coll Cardiol 60(7):628–636CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Mohanty S, Gianni C, Mohanty P et al (2016) Impact of rotor ablation in nonparoxysmal atrial fibrillation patients: results from the randomized OASIS trial. J Am Coll Cardiol 68(3):274–282CrossRefPubMed Mohanty S, Gianni C, Mohanty P et al (2016) Impact of rotor ablation in nonparoxysmal atrial fibrillation patients: results from the randomized OASIS trial. J Am Coll Cardiol 68(3):274–282CrossRefPubMed
36.
Zurück zum Zitat Haïssaguerre M et al (2014) How to map and ablate rotors. Heart Rhythm V90 (Vortrag) Haïssaguerre M et al (2014) How to map and ablate rotors. Heart Rhythm V90 (Vortrag)
37.
Zurück zum Zitat Lemes C, Wissner E, Metzner A et al (2014) Rotor mapping in atrial fibrillation using a novel body-surface mapping system. Clin Res Cardiol 103:V555 Lemes C, Wissner E, Metzner A et al (2014) Rotor mapping in atrial fibrillation using a novel body-surface mapping system. Clin Res Cardiol 103:V555
38.
Zurück zum Zitat Wißner E, Lemes C, Rausch P et al (2014) Use of a novel system for noninvasive cardiac electrophysiology studies: stability of rotors over time in patients with atrial fibrillation. Clin Res Cardiol 103:V172 Wißner E, Lemes C, Rausch P et al (2014) Use of a novel system for noninvasive cardiac electrophysiology studies: stability of rotors over time in patients with atrial fibrillation. Clin Res Cardiol 103:V172
39.
Zurück zum Zitat Lemes C, Sohns C, Maurer T et al (2016) Rotor distribution and stability in atrial fibrillation using a non invasive body-surface system. DGK Herbsttagung, S 526 Lemes C, Sohns C, Maurer T et al (2016) Rotor distribution and stability in atrial fibrillation using a non invasive body-surface system. DGK Herbsttagung, S 526
Metadaten
Titel
Katheterablation von persistierendem Vorhofflimmern
„Where do we go?“
verfasst von
Dr. med. C. Lemeš
K.-H. Kuck
S. Mathew
Publikationsdatum
12.05.2017
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 4/2017
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-017-4566-1

Weitere Artikel der Ausgabe 4/2017

Herz 4/2017 Zur Ausgabe

Passend zum Thema

ANZEIGE

Leitlinien-Update und neue Pocket-Leitlinie vorgestellt von Prof. Möllmann

Die neue Leitlinie zur Behandlung von Herzklappenerkrankungen der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS) ist ab jetzt als deutschsprachige Pocket-Leitlinien abrufbar. Die wichtigsten Neuerungen des Updates finden Sie hier von Prof. Dr. Helge Möllmann aus Dortmund für Sie zusammengefasst.

ANZEIGE

Expertenrat: Wer profitiert vom Vorhofohr-Verschluss

Der interventionelle Verschluss des linken Vorhofohrs ist eine in den Leitlinien empfohlene Alternative zur oralen Antikoagulation bei Menschen mit Vorhofflimmern. Bei welchen Patientinnen und Patienten Sie konkret an diese Alternative denken sollten – dazu gibt Kardiologe PD Dr. Zisis Dimitriadis alltagstaugliche Tipps.

ANZEIGE

Abbott Structural Heart

Content Hub

Wir helfen Menschen mit Strukturellen Herzerkrankungen ihre Lebensqualität zu verbessern. Entdecken Sie unser einzigartiges Produktportfolio für ihre Patienten.

Abbott Medical GmbH